News Conference News TCT 2012 Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions October 25, 2012
News Conference News TCT 2012 Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness October 25, 2012
News Conference News TCT 2012 Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5 October 24, 2012
News Conference News TCT 2012 Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology October 24, 2012
News Conference News TCT 2012 DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS October 24, 2012
News Conference News TCT 2012 COURAGE, FAME: Revascularization More Effective Than OMT October 22, 2012
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011
News Conference News PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis November 27, 2011
News Conference News Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version November 20, 2011
News Conference News Two New SES Show Improvement Over First-Generation Stents Yael L. Maxwell November 10, 2011
News Conference News EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version November 10, 2011
News Conference News SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology November 08, 2011
News Conference News Long-term Outcomes Improved with Biodegradable Biolimus-Eluting Stent vs. Permanent Polymer SES November 08, 2011